Related Experiment Video
Updated: Jun 18, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Dilated Cardiomyopathy in Children: A Diverse Etiological Profile
Soukayna Setouani1, Asmae Mehdaoui1, Nidale Hazzab1
1Pediatrics, Centre Hospitalier Universitaire Mohammed VI de Tanger, Tangier, MAR.
Insights
Dilated cardiomyopathy in children is common and serious, with varied causes like myocarditis and genetic factors. Early diagnosis and treatment are crucial for improving outcomes and reducing the significant mortality rate.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Research
- Clinical Pediatrics
Background:
- Dilated cardiomyopathy (DCM) is the leading cause of pediatric heart failure and mortality.
- Accurate etiological diagnosis of pediatric DCM is challenging, especially in resource-limited areas.
Purpose of the Study:
- To investigate the clinical characteristics, etiological spectrum, and outcomes of pediatric dilated cardiomyopathy.
- To highlight the importance of early etiological investigation for improved management.
Main Methods:
- Retrospective descriptive study over 26 months at University Hospital of Tangier, Morocco.
- Inclusion of all pediatric patients diagnosed with dilated cardiomyopathy.
- Analysis of clinical, etiological, and outcome data.
Main Results:
- Fifty percent of pediatric cardiomyopathy cases were DCM (20/40), with a mean age of 4 years and male predominance.
- Common etiologies included myocarditis, genetic causes, and aortic coarctation; 15% remained idiopathic.
- Mortality was 20%, but 65% of patients showed improved cardiac function with treatment.
Conclusions:
- Pediatric dilated cardiomyopathy is a severe condition with diverse causes and significant mortality.
- Prompt etiological diagnosis is vital for effective management and better patient prognosis.
Abstract:
Introduction Dilated cardiomyopathy (DCM) is the most common form of cardiomyopathy in children and represents a major cause of heart failure and mortality. Its etiological diagnosis often remains complex, particularly in resource-limited settings. Methods This was a retrospective descriptive study conducted over a 26‑month period (February 2024 to April 2026) in the pediatric department of the University Hospital of Tangier, Morocco. All children diagnosed with dilated cardiomyopathy were included. Clinical, etiological, and outcome data were analyzed. Results Among 40 cases of cardiomyopathy, 20 (50%) were dilated cardiomyopathy. The mean age was four years (range: two months to 13 years), with a male predominance (sex ratio = 1.8). All patients were symptomatic at diagnosis. The mean ejection fraction was 34.6%. Mitral regurgitation was observed in 70% of cases, and intracavitary thrombus in 5%. Identified etiologies included myocarditis (15%), genetic causes (15%), aortic coarctation (15%), chronic renal failure (10%), rickets-related hypocalcemia (10%), coronary anomalies (10%), and L‑carnitine deficiency (5%). No etiology was identified in 15% of cases. All patients received heart failure treatment. Mortality was 20%, while 65% of patients showed improvement in cardiac function during follow‑up. Conclusion Dilated cardiomyopathy in children remains a serious condition with multiple etiologies and a non‑negligible mortality rate. Early etiological investigation is essential to guide management and improve prognosis.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Myocarditis I: Introduction

